hexaminolevulinate hydrochloride · Photocure Asa · NDA 022555
Cysview Kit
Earliest generic entry, as listed
4 Jan 2038
Blocked by patent: US 11235168. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11235168 | use U-2250 | 4 Jan 2038 |
| US 10556010 | use U-2250 | 19 Dec 2036 |
| US 11311620 | use U-2250 | 19 Dec 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022555 · 001 · RLD | for solution, intravesical | 100MG/VIAL | 4 Jan 2038 |